Industry & Mining · Pharmaceutical active pharmaceutical ingredients (APIs) production

Pharmaceutical active pharmaceutical ingredients (APIs) production in Germany in 2026

Germany, the home of 'Big Pharma' (Bayer, Merck), produces virtually no finished pharmaceutical active ingredients (APIs) in tonnage terms. In 2026, output was 0 tonnes, which nonetheless corresponds to 33-th place out of 197 countries. German companies have shifted API synthesis to Asia, focusing on high-margin research, drug development, and finished dosage form production at plants in Rhineland-Palatinate and Baden-Württemberg.

Data for 2026 · unit: tonnes
Position

Germany world ranking

#33 / 197

Country position on the scale from last to first place for this indicator.

DE
#33
#197#1
Trend

Change over time

Change in indicator over the available period.

200
1950
1.5 K
1990
800
2000
200
2010
50
2020
0
2025
0
2026

Values — tonnes

Comparison

Top countries by Pharmaceutical active pharmaceutical ingredients (APIs) production

Where Germany stands in the world ranking.

Full world rankingarrow_forward
Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical active pharmaceutical ingredients (APIs) production in Germany — how much?
Based on 2026 data — 0 tonnes. This is rank #33 out of 197 countries.
What is Germany's rank by Pharmaceutical active pharmaceutical ingredients (APIs) production?
Germany ranks #33 out of 197 countries in the world ranking by «Pharmaceutical active pharmaceutical ingredients (APIs) production».
How has Pharmaceutical active pharmaceutical ingredients (APIs) production changed in Germany?
Over the available period the indicator changed from 200 to 0 tonnes.